NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience.
Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ.
Bagley AF, et al.
Clin Transl Radiat Oncol. 2022 Jan 11;33:66-69. doi: 10.1016/j.ctro.2021.12.012. eCollection 2022 Mar.
Clin Transl Radiat Oncol. 2022.
PMID: 35097226
Free PMC article.